Investigating a Mediterranean diet to slow vision loss in older adults with AMD
Feasibility Studies for the Future Mediterranean Glucose Lowering Dietfor Vision Extension in AMD (M-GLOVE-AMD)
This study is looking at whether following a Mediterranean diet can help slow down vision loss from age-related macular degeneration (AMD) in people over 55 who don’t have diabetes and are in the early stages of the condition.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10794815 on NIH RePORTER |
What this research studies
This research focuses on age-related macular degeneration (AMD), a common cause of vision loss in individuals over 55. It aims to assess the feasibility of a Mediterranean diet, known for its health benefits, in slowing the progression of AMD in non-diabetic patients with early-stage disease. The study will involve dietary interventions to shift participants from a typical Western diet to a low glycemic Mediterranean diet, while also evaluating advanced imaging techniques and potential biomarkers. The ultimate goal is to lay the groundwork for a larger multicenter study comparing this dietary approach to standard dietary practices.
Who could benefit from this research
Good fit: Ideal candidates for this research are non-diabetic individuals aged 55 and older who have been diagnosed with early-stage age-related macular degeneration.
Not a fit: Patients with advanced AMD or those who are diabetic may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a cost-effective dietary intervention to help preserve vision in older adults with AMD.
How similar studies have performed: Previous observational studies have suggested that Mediterranean diets may help slow AMD progression, indicating potential success for this dietary approach.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Hartnett, Mary Elizabeth Ruth — Stanford University
- Study coordinator: Hartnett, Mary Elizabeth Ruth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.